Loading clinical trials...
Loading clinical trials...
A Phase I, Open-label, Multiple-dose, Dose-escalation Study To Assess the Safety and Tolerability of AZD8931 Monotherapy in Japanese Patients With Advanced Solid Malignancies and in Combination With Paclitaxel in Japanese Female Patients With Advanced Breast Cancer
Conditions
Interventions
AZD8931
Paclitaxel
Locations
1
Japan
Research Site
Osaka, Japan
Start Date
October 1, 2009
Primary Completion Date
April 1, 2012
Completion Date
April 1, 2012
Last Updated
July 10, 2014
NCT05245812
NCT04704661
NCT05673200
NCT07169851
NCT04550494
NCT05372640
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions